Cabaletta Bio

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
$4,010
Gross Profit
-426
-393
3,674
EBITDA
-33,046
-29,853
-27,638
-22,810
EBIT
-30,279
-28,031
-23,146
Net Income
-30,629
-27,602
-25,047
-20,886
Net Change In Cash
0
0
0
4,010
Free Cash Flow
-20,576
-21,559
-24,800
-16,633
Cash
170,608
178,613
175,293
193,238
Basic Shares
49,445
49,445
49,302
44,435

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$
Gross Profit
-1,426
-3,684
-733
EBITDA
-73,234
-52,961
-45,580
-33,479
EBIT
-74,660
-54,139
-46,313
-33,833
Net Income
-67,675
-51,811
-45,532
-32,491
Net Change In Cash
0
0
0
Cost of Revenue
-40,615
-34,775
Free Cash Flow
-54,236
-48,833
-35,275
-27,405
Cash
193,238
81,607
122,222
101,429
Basic Shares
40,945
29,342
25,737
23,145

Earnings Calls

Quarter EPS
2024-09-30
-$0.62
2024-06-30
-$0.56
2024-03-31
-$0.51
2023-12-31
-$0.46